NuPlant's complete range of products has us poised to revolutionise tissue culture
SmartClone™ permits previously impractical changes to agar components.
Better controlling physiology results in superior plantlets.
The SmartClone systems have been tested globally in North America, China, Europe and Australia.
SmartClone™ is a disruptive technology in a conservative industry, providing tremendous growth potential.
NuPlant’s success is due to its small team interacting closely and rapidly iterating on new concepts.
A suite of four international patents have been developed fully protecting NuPlant’s revolutionary systems.
NuPlant has no direct competitors but instead competes with different players in different product lines. This highlights the uniqueness of our integrated product solutions in the market. Among those competitors are the several Australian and international companies, none of which offer the comprehensive benefits of the SmartClone™ and Janus systems.
NuPlant has a simple business model. We sell our range of hardware, software and consumable products at reasonable profit. We do not compete with our clients through operations that apply our technology. We sell directly in some markets, but have agents in countries like China where establishing marketing and support teams would represent a challenge.
NuPlant is exploring expansion to new markets and is open to proposals from suitable organisations that have appropriate support capabilities and effective market access.